Systematic analysis of the role of bacterial Hfq-interacting sRNAs in the response to antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 6, 2015, Pages 1659-1668

  Kim, Taeyeon ^a   Bak, Geunu ^a   Lee, Juyeon ^a   Kim, Kwang sun ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

Author keywords

Hfq protein; Multidrug resistance; Small non coding RNA; Species conservation

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; APRAMYCIN; BACTERIAL PROTEIN; CEFALOTIN; CEFIXIME; CEFOTAXIME; CEFUROXIME; GENTAMICIN; HFQ PROTEIN; KANAMYCIN; LEVOFLOXACIN; LOMEFLOXACIN; MEROPENEM; MINOCYCLINE; NALIDIXIC ACID; NEOMYCIN; NORFLOXACIN; SMALL UNTRANSLATED RNA; STREPTOMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; HOST FACTOR 1;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIABILITY; CELL COUNT; ESCHERICHIA COLI; GENE EXPRESSION; GENE IDENTIFICATION; GENE INACTIVATION; GENE LIBRARY; GENE OVEREXPRESSION; GENE TARGETING; KNOCKOUT GENE; MICF GENE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN RNA BINDING; RYEB GENE; SALMONELLA; ADAPTATION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; PHYSIOLOGICAL STRESS;

ADAPTATION, PHYSIOLOGICAL; ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENE KNOCKOUT TECHNIQUES; HOST FACTOR 1 PROTEIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; RNA, SMALL UNTRANSLATED; SALMONELLA; STRESS, PHYSIOLOGICAL;

EID: 84930511038     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv042     Document Type: Article

References (47)

1. Taubes G. The bacteria fight back. Science 2008;321:356-61.
2. Szmolka A, Nagy B. Multidrug resistant commensal Escherichia coli in animals and its impact for public health. Front Microbiol 2013;4:258.
3. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010;74:417-33.
4. De Lay N, Schu DJ, Gottesman S. Bacterial small RNA-based negative regulation: Hfq and its accomplices. J Biol Chem 2013;288:7996-8003.
5. Gottesman S, Storz G. Bacterial small RNA regulators: versatile roles and rapidly evolving variations. Cold Spring Harb Perspect Biol 2011;3: doi:10.1101/cshperspect.a003798.
6. Gottesman S, McCullen CA, Guillier M et al. Small RNA regulators and the bacterial response to stress. Cold Spring Harb Symp Quant Biol 2006;71:1-11.
7. Beisel CL, Storz G. Base pairing small RNAs and their roles in global regulatory networks. FEMS Microbiol Rev 2010;34:866-82.
8. Waters LS, Storz G. Regulatory RNAs in bacteria. Cell 2009;136:615-28.
9. Storz G, Vogel J, Wassarman KM. Regulation by small RNAs in bacteria: expanding frontiers. Mol Cell 2011;43:880-91.
10. Sauer E. Structure and RNA-binding properties of the bacterial LSm protein Hfq. RNA Biol 2013;10:610-8.
11. Sobrero P, Valverde C. The bacterial protein Hfq: much more than a mere RNA-binding factor. Crit Rev Microbiol 2012;38:276-99.
12. Vogel J, Luisi BF. Hfq and its constellation of RNA. Nat Rev Microbiol 2011;9:578-89.
13. Fender A, Elf J, Hampel K et al. RNAs actively cycle on the Sm-like protein Hfq. Genes Dev 2010;24:2621-6.
14. Yamada J, Yamasaki S, Hirakawa H et al. Impact of the RNA chaperone Hfq on multidrug resistance in Escherichia coli. J Antimicrob Chemother 2010;65:853-8.
15. Kendall MM, Gruber CC, Rasko DA et al. Hfq virulence regulation in enterohemorrhagic Escherichia coli O157:H7 strain 86-24. J Bacteriol 2011;193:6843-51.
16. Allam US, Krishna MG, Lahiri A et al. Salmonella enterica serovar Typhimurium lacking hfq gene confers protective immunity against murine typhoid. PLoS One 2011;6: e16667.
17. Monteiro C, Papenfort K, Hentrich K et al. Hfq and Hfq-dependent small RNAs are major contributors to multicellular development in Salmonella enterica serovar Typhimurium. RNA Biol 2012;9:489-502.
18. Nielsen JS, Lei LK, Ebersbach T et al. Defining a role for Hfq in Gram-positive bacteria: evidence for Hfq-dependent antisense regulation in Listeria monocytogenes. Nucleic Acids Res 2010;38:907-19.
19. Moon K, Gottesman S. A PhoQ/P-regulated small RNA regulates sensitivity of Escherichia coli to antimicrobial peptides. Mol Microbiol 2009;74:1314-30.
20. Salvail H, Caron MP, Bélanger J et al. Antagonistic functions between the RNA chaperone Hfq and an sRNA regulate sensitivity to the antibiotic colicin. EMBO J 2013;32:2764-78.
21. Gutierrez A, Laureti L, Crussard S et al. b-Lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity. Nat Commun 2013;4:1610.
22. Chou JH, Greenberg JT, Demple B. Posttranscriptional repression of Escherichia coli OmpF protein in response to redox stress: positive control of the micF antisense RNA by the soxRS locus. J Bacteriol 1993;175:1026-31.
23. Baisa G, Stabo NJ, Welch RA. Characterization of Escherichia coli D-cycloserine transport and resistant mutants. J Bacteriol 2013;195:1389-99.
24. Vogel J, Papenfort K. Small non-coding RNAs and the bacterial outer membrane. Curr Opin Microbiol 2006;9:605-11.
25. Delcour AH. Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 2009;1794:808-16.
26. Delihas N, Forst S. MicF: an antisense RNA gene involved in response of Escherichia coli to global stress factors. J Mol Biol 2001;313:1-12.
27. Nishino K, Yamasaki S, Hayashi-Nishino M et al. Effect of overexpression of small non-coding DsrA RNA on multidrug efflux in Escherichia coli. J Antimicrob Chemother 2011;66:291-6.
28. Mandin P, Gottesman S. Integrating anaerobic/aerobic sensing and the general stress response through the ArcZ small RNA. EMBO J 2010;29:3094-107.
29. Baba T, Ara T, Hasegawa M et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2006;2:2006.0008.
30. Blank K, Hensel M, Gerlach RG. Rapid and highly efficient method for scarless mutagenesis within the Salmonella enterica chromosome. PLoS One 2011;6: e15763.
31. Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 2008;3:163-75.
32. Saini V, Riekerink RGMO, McClure JT et al. Diagnostic accuracy assessment of Sensititre and agar disk diffusion for determining antimicrobial resistance profiles of bovine clinical mastitis pathogens. J Clin Microbiol 2011;49:1568-77.
33. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24. CLSI, Wayne, PA, USA, 2014.
34. Zaslaver A, Bren A, Ronen M et al. A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat Methods 2006;3:623-8.
35. Kim KS, Park S, Lee S et al. A novel fluorescent reporter system for monitoring and identifying RNase III activity and its target RNAs. RNA Biol 2012;9:1167-76.
36. Hayashi-Nishino M, Fukushima A, Nishino K. Impact of hfq on the intrinsic drug resistance of Salmonella enterica serovar Typhimurium. Front Microbiol 2012;3:205.
37. Raghavan R, Groisman EA, Ochman H. Genome-wide detection of novel regulatory RNAs in E. coli. Genome Res 2011;21:1487-97.
38. Skippington E, Ragan MA. Evolutionary dynamics of small RNAs in 27 Escherichia coli and Shigella genomes. Genome Biol Evol 2012;4:330-45.
39. Kery MB, Feldman M, Livny J et al. TargetRNA2: identifying targets of small regulatory RNAs in bacteria. Nucleic Acids Res 2014;42: W124-9.
40. Wright PR, Georg J, Mann M et al. CopraRNA and IntaRNA: predicting small RNA targets, networks and interaction domains. Nucleic Acids Res 2014;42: W119-23.
41. Aiba H, Matsuyama S, Mizuno T et al. Function of micF as an antisense RNA in osmoregulatory expression of the ompF gene in Escherichia coli. J Bacteriol 1987;169:3007-12.
42. Holmqvist E, Unoson C, Reimegard J et al. A mixed double negative feedback loop between the sRNA MicF and the global regulator Lrp. Mol Microbiol 2012;84:414-27.
43. Ernst ME, Ernst EJ, Klepser ME. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones? Am J Health Syst Pharm 1997; 54:2569-84.
44. Davis R, Bryson HM. Levofloxacin: a review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 1994;47:677-700.
45. Jang WH, Yoo DH, Park SW. Prevalence of and risk factors for levofloxacin-resistant E. coli isolated from outpatients with urinary tract infection. Korean J Urol 2011;52:554-9.
46. Johnson L, Sabel A, Burman WJ et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 2008;121:876-84.
47. Caron F, Etienne M. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 2010;123: e13.